ClearLight Dx Raises $2.8M

May 08, 2018

|

NEW YORK (360Dx) – ClearLight Diagnostics said today that it has completed a $2.77 million financing round.

Participants in the financing round included CS Investors, Pivotal Paramount Investment, and Stanford University. The financing will be used to continue development of ClearLight's platform, it said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

ClearLight Dx Raises $2.8M

To read the full story....

Breaking News

Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

German Stores to Begin Selling COVID-19 Rapid Antigen Tests for Home Use

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents

DermTech Q4 Revenues Up 31 Percent

In Brief This Week: Abbott Laboratories, LexaGene, Caris Life Sciences, SQI Diagnostics, and More

What's Popular?

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

OraSure Technologies Updates Plan for SARS-CoV-2 Antigen Self-Test

Agilent Charges Into Liquid Biopsy Space with Resolution Biosciences Acquisition

Fulgent Genetics Q4 Revenues Skyrocket

C2i Genomics Acquires Sequencing Lab QNA Dx

Sponsorships